U.S. markets close in 1 hour 53 minutes

Collegium Pharmaceutical, Inc. (COLL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
22.66+0.01 (+0.02%)
As of 2:06PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close22.65
Open22.70
Bid22.57 x 800
Ask22.60 x 1100
Day's Range22.39 - 22.79
52 Week Range15.66 - 26.91
Volume72,639
Avg. Volume252,479
Market Cap798.534M
Beta (5Y Monthly)0.99
PE Ratio (TTM)19.23
EPS (TTM)1.18
Earnings DateAug 03, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.57
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
2% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Collegium Announces Publication of Real-World Data in Journal of Pain Research
    GlobeNewswire

    Collegium Announces Publication of Real-World Data in Journal of Pain Research

    STOUGHTON, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced a publication titled, “Nonmedical Use of Xtampza® ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-world Data from the Addiction Severity Index – Multimedia Version (ASI-MV®),” was published in the peer-reviewed medical journal, Journal of Pain R

  • Under Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid Crisis
    Motley Fool

    Under Biden's Budget, These 2 Little-Known Biotechs Could Help End the Opioid Crisis

    The White House's plans to address the U.S. opioid crisis could be good news for Heron Therapeutics and Collegium Pharmaceutical, makers of safer pain management drugs.

  • Collegium to Participate in Upcoming Investor Conference
    GlobeNewswire

    Collegium to Participate in Upcoming Investor Conference

    STOUGHTON, Mass., May 20, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conference: Jefferies Virtual Healthcare Conference Format: Fireside chat Date: Wednesday, June 2, 2021Time: 4:30 PM Eastern Time The presentation will be webcast live and may be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcast will be available on the Company’s website for approximately 30 days after the event. About Collegium Pharmaceutical, Inc. Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com. Contact: Alex Dasallaadasalla@collegiumpharma.com